BioCentury
ARTICLE | Company News

American Biogenetic deal

January 31, 1994 8:00 AM UTC

MABXA (Notre Dame, Ind.) acquired several therapeutics to treat epilepsy from The National University of Ireland (Dublin). MABXA’s ABS Global Scientific Network, an entity where scientists from both p...